• Users Online: 313
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe News Contacts Login 


 
 Table of Contents  
REVIEW ARTICLE
Year : 2022  |  Volume : 6  |  Issue : 3  |  Page : 127-138

A Narrative Review on Exercise and Cardiovascular Events: “Primum Non Nocere”


1 First Cardiology Clinic, Medical School, Hippokration Hospital, National and Kapodistrian University of Athens, Athens, Greece
2 3rd Department of Cardiology, School of Medicine, Sotiria Chest Disease Hospital, National and Kapodistrian University of Athens, Athens, Greece
3 Athens Heart Center, Athens Medical Center, Athens, Greece

Date of Submission10-Aug-2022
Date of Acceptance09-Sep-2022
Date of Web Publication30-Sep-2022

Correspondence Address:
Dr. Kyriakos Dimitriadis
Dardanellion 146-148, Athens, 17123
Greece
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/hm.hm_25_22

Rights and Permissions
  Abstract 

Exercise provides beneficial effects on the primary and secondary prevention of numerous chronic conditions, including cardiovascular disease, diabetes mellitus, and malignancies. Despite its indisputable benefits, exercise can rarely trigger major adverse cardiovascular events such as ventricular arr hythmias, myocardial infarction, or even sudden cardiac arrest in susceptible individuals. Physiological changes that occur during exercise, including increased sympathetic activity and cardiac oxygen requirements, may account for ischemia and trigger ventricular ectopy with eventually adverse outcomes. Tailored preparticipation screening for exercise and sports engagement is fundamental to unveiling underlying pathological conditions. The present review summarizes the overall impact of exercise on cardiovascular health and highlights the recommended prevention strategies.

Keywords: Cardiovascular disease, exercise, prevention, training programs


How to cite this article:
Dimitriadis K, Bletsa E, Lazarou E, Leontsinis I, Stampouloglou P, Dri E, Sakalidis A, Pyrpyris N, Tsioufis P, Siasos G, Tsiachris D, Tsioufis K. A Narrative Review on Exercise and Cardiovascular Events: “Primum Non Nocere”. Heart Mind 2022;6:127-38

How to cite this URL:
Dimitriadis K, Bletsa E, Lazarou E, Leontsinis I, Stampouloglou P, Dri E, Sakalidis A, Pyrpyris N, Tsioufis P, Siasos G, Tsiachris D, Tsioufis K. A Narrative Review on Exercise and Cardiovascular Events: “Primum Non Nocere”. Heart Mind [serial online] 2022 [cited 2023 Feb 8];6:127-38. Available from: http://www.heartmindjournal.org/text.asp?2022/6/3/127/357546


  Introduction Top


The positive impact of exercise on the primary and secondary prevention of numerous chronic conditions, including cardiovascular disease (CVD), diabetes mellitus, and several malignancies, among others, has long been well established.[1],[2] Engaging in regular exercise has been proven to reduce the risk of CVD with a dose-response relationship.[3] Despite its beneficial effects, exercise can occasionally trigger major adverse cardiovascular events in predisposed individuals. The residual risk of acute cardiovascular events remains during and shorty after physical exertion, and its severity is correlated with the intensity of exercise, as well as the previous physical condition.[4] Especially, vigorous physical activity might be paradoxically detrimental to susceptible individuals, triggering the development of acute coronary syndromes (ACS), life-threatening arrhythmias, sudden cardiac arrest, and sudden cardiac death (SCD) in the presence of underlying CVD.[5],[6] Unexpected deaths in young athletes have raised serious concerns since the 1960s, when autopsy-based studies investigated the possible mechanisms of such events.[7],[8] Notably, the majority of these athletes experienced sudden death during or shortly after severe exertion on the athletic field, while the most common cause of death in these series was hypertrophic cardiomyopathy (HCM). In recent years, there has been an increasing interest in reducing SCD rates in athletes.[9] In 2005, the first recommendations on the eligibility criteria for sports participation were published by the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology (ESC).[10] Since then, several updates have been released, with the most recent guidelines on Sports Cardiology and Exercise being published by the ESC in 2020.[11],[12],[13]

According to the ESC relevant guidelines, athletes are defined as “individuals of young or adult age, either amateur or professional, who are engaged in regular exercise training and participate in official sports competition.”[14] Similarly, the American Heart Association (AHA) and others define a competitive athlete as an individual involved in regular (usually intense) training in organized individual or team sports, with an emphasis on competition and performance.[15],[16] Young athletes are defined as individuals ≤35 years old. Athletes are further categorized as elite, competitive, and recreational, based mainly on exercise volume. Elite athletes are considered those who exercise more than 10 h/week, competitive athletes more than 6 h/week, whereas recreational athletes are finally considered those that exercise for a minimum of 4 h/week. Exercisers differ from athletes regarding the intent and motivation of activity. In specific, exercisers are considered to be individuals who participate in sports solely with the goal to maintain health and fitness.[17] However, the above-mentioned categories may overlap, as exercisers and recreational athletes may occasionally engage in vigorous physical activity. For a more effective quantification of exercise intensity, metabolic equivalents (METs) are employed to estimate energy expenditure.[18] Physical activities of at least 6 METs are considered of vigorous intensity.[19]

Physiological changes occurring during exercises, such as increased sympathetic activity and cardiac oxygen requirements, may lead to ischemia and trigger ventricular ectopy.[20] Thus, there is an increasing risk of acute cardiovascular events in susceptible individuals with underlying cardiac disorders, which holds especially true in previously asymptomatic patients with undiagnosed diseases.[21] In this line, a tailored preparticipation screening is fundamental for the detection of underlying pathological conditions.[22] Early detection of CVD leads to a substantial reduction of exercise-related adverse events through the implementation of disease-specific interventions and individualized recommendations regarding the volume and intensity of exercise.[23] This narrative review aims to summarize the physiological impact of physical activity on cardiovascular health, discuss the pathological substrate of acute cardiovascular events and highlight the recommended prevention strategies.


  Main Causes of Exercise-Related Cardiovascular Events Top


The pathological basis of exertion-related acute cardiovascular events varies significantly with age.[20] Younger individuals (<35 years) suffer mainly from hereditary or congenital cardiovascular abnormalities, whereas in older individuals, the most common pathological finding is coronary artery disease (CAD).[24],[25] In a study analyzing the incidence of SCD in US college athletes, 1.6 deaths per 100,000 person-years were attributed to confirmed or suspected CVD.[26] SCD in young athletes may appear in a number of disorders, which are divided into two main categories, namely structural and electrical cardiac abnormalities.[27] Notably, in apparently healthy young athletes, the overall prevalence of these disorders is approximately 0.3%.[21],[28]

Among structural disorders, HCM is the most common cause of SCD in young male athletes, accounting for 39% of sudden male deaths in the United States (US) National Registry of Athletes.[29] The diagnosis of HCM is based on the presence of unexplained left ventricular (LV) hypertrophy, defined as a maximum end-diastolic wall thickness ≥15 mm, in any myocardial segment on echocardiography, cardiovascular magnetic resonance (CMR), or computed tomography imaging (or wall thickness ≥13 mm in the context of a family history of definite HCM or a positive genetic test).[30] Nevertheless, the diagnosis of HCM in athletes sometimes can be challenging. LV hypertrophy is not an exceptional finding in male athletes (the so-called athletic heart), overlapping morphologically with emerging HCM,[12] though small imaging differences may be valuable to distinguish the two conditions. Notably, athletes with HCM have an asymmetric pattern of LV hypertrophy,[30],[31] and approximately one-third of athletes may have the apical variant,[32] while athletes with physiological LV hypertrophy show a more homogeneous and symmetric distribution of wall thickness.[33] Moreover, LV end-diastolic cavity size in individuals with HCM is normal or reduced compared to athletes with physiological LV hypertrophy, where an enlarged cavity is observed.[34] Other subtle structural anomalies, such as elongation of mitral valve leaflets, anomalous insertion of papillary muscles, myocardial crypts, and recesses may also coexist among athletes with HCM.[30],[31]

Complex ventricular arrhythmias such as ventricular tachycardia and ventricular fibrillation triggered by intense physical exertion may also develop as a result of electrical instability predisposing to cardiac arrhythmias in these individuals.[35] In more detail, chaotic LV myocardial architecture, consisting of hypertrophic myocytes with bizarre shapes and multiple intracellular connections, increased intima and medial collagen matrix deposition, as well as myocardial fibrosis, are considered to be great substrates for the development of fatal arrhythmias in HCM, while intense physical exertion seems to be the triggering factor, provoking thus the phenomenon of electrical instability.[35],[36] Notably, local conduction delay or block, abnormally fractionated electrograms, and reduced bipolar voltages represent typical electrophysiological findings.[37] In contrast, in female athletes, HCM is less common (ratio males/females, 3/2), and accordingly, in some instances of exercise-related SCDs, no structural disorders are found at autopsy.[35],[38]

Nevertheless, the risk of fatal arrhythmias during exercise and sport participation differs among all individuals with HCM, and as a result, all athletes with HCM are not restricted from competitive sports. Interestingly, current literature reveals that individuals with HCM who continue participating in sports after implantable cardioverter-defibrillator (ICD) implantation do not experience an increased number of shocks during exercise.[39],[40] Thus, an option for participation might be achievable among specific athletes with HCM after careful evaluation, proper management, and patient-focused counseling.

Congenital coronary-artery abnormalities/malformations represent the second-most common autopsy finding in young athletes, accounting for approximately 17% of SCDs in the US.[41] In particular, during exercise, ectopic coronary arteries can be compressed between the aorta and pulmonary artery trunk, leading to acute myocardial ischemia.[42] In addition, valvular disease, mainly aortic stenosis and mitral valve prolapse (MVP), has also been implicated in exertion-related SCD. Valvular regurgitation and stenosis have been correlated with compensatory ventricular enlargement, hypertrophy, and dysfunction.[43] An increase in stroke volume, heart rate, as well as myocardial contractility during physical exertion might further deteriorate valvular dysfunction.[11] As a result, patients with the valvular disease are more prone to experience syncope, myocardial ischemia, atrial or ventricular arrhythmias, as well as SCD.[43] Although individuals with MVP have an overall good prognosis, in the Italian pathology registry, 7% of SCDs were attributed to “arrhythmic MVP,” with the majority being females.[44],[45]

Specific electrical and structural abnormalities may be valuable tools to identify high-risk patients. In more detail, inverted T-waves in inferior leads and ventricular extrasystoles of the right bundle branch block create an arrhythmogenic milieu, which may lead to sustained and potentially life-threatening arrhythmias among patients with MVP.[44] Furthermore, excessive stretch by the flail leaflets causes myocardial scarring, which serves as an arrhythmogenic substrate in these patients.[46]

Other disorders possibly less commonly responsible for SCDs in young athletes are dilated cardiomyopathy, Marfan's syndrome, arrhythmogenic right ventricular cardiomyopathy (ARVC) and myocarditis. The proximate cause of death in the above-mentioned conditions is ventricular arrhythmias, except for Marfan syndrome, where aortic rupture is the main cause of death.[20] Finally, atherosclerotic CAD is rarely encountered in exercise-induced SCD in young individuals, especially in those with a genetic defect in low-density lipoprotein.[20] It should be, however, emphasized that approximately 3% of young athletes depict normal cardiac structure on autopsy.[47] These deaths can be attributed to arrhythmogenic disorders such as channelopathies (i.e. long QT syndrome and Brugada syndrome), Wolff-Parkinson-White syndrome, and catecholaminergic polymorphic tachycardia.[48],[49],[50],[51],[52] Cohort studies conducted in the US and United Kingdom in athletes with SCD revealed a high rate of structurally normal hearts during the autopsy, suggesting a high prevalence of sudden arrhythmic death syndrome.[53],[54],[55]

It should be, however, emphasized that the majority of exercise-related SCDs occur in older athletes compared to their younger counterparts. In a prospective French study addressing exercise-related SCD in the general population, only 6% regarded young competitive athletes.[56] The risk of exertion-related adverse events, such as myocardial infarction (MI) and SCD, increases during strenuous exercise in “senior” athletes. However, it is inversely associated with regular exertion levels. Most important, sedentary people have an increased risk of SCD during vigorous exercise.[57] Moreover, there is a dose-response effect, with the relative risk of myocardial infarction being reduced in individuals with regular weekly physical activity.[58] From an epidemiological point of view, CAD accounts for more than 80% of SCDs in athletes older than 35.[59],[60] The proximate cause of death in the latter cases is ischemia-induced ventricular arrhythmias; however, the mechanism has not been completely elucidated.[61] Sympathetic activation leading to ischemia and arrhythmias, metabolic factors, activation of the hemostatic mechanisms, and hemodynamic changes causing destabilization and rupture of the vulnerable atheromatous plaques represent possible mechanisms underlying SCD.[62] Similar to younger athletes, a number of other disorders may be responsible for a minority of SCDs in older athletes, such as HCM, ARVC, myocarditis, valvular disease, and channelopathies, among others.[63]

Exercise-related cardiovascular complications might be the first clinical manifestation of occult CVD. Possible prodromal symptoms that exercising individuals with CVD may experience, include the following: pain or discomfort in the chest, neck, jaw, arms, or other areas, gradually-deteriorating fatigue, heartburn, gastrointestinal symptoms, excessive or unusual breathlessness, dizziness, palpitations, as well as severe headache, ankle swelling, burning or cramping sensations in the lower extremities when walking.[24],[64] It is reported that individuals who experienced exercise-triggered cardiovascular events occasionally had prodromal symptoms, which were underestimated or even ignored or downgraded by themselves or their attending physicians.[24] Consequently, it is of major importance for exercising individuals and coaches to be aware of the possible prodromal cardiac symptoms, and if such symptoms appear, exercise should be discontinued, and medical advice should be promptly sought. Despite the above-reported concerns, the overall risk of adverse cardiovascular events during and after exercise remains still quite low, especially in individuals with long-standing physical activity.[65]


  Screening for Participation in Sports Top


A number of strategies have been proposed for the prevention of exercise-related acute cardiovascular events. At present, it is well established that early detection of potentially life-threatening disorders among athletes requires a detailed risk stratification, eventually with patient-centered interventions and exercise modifications, aiming at diminishing cardiovascular morbidity and mortality.[21],[66] Preparticipation health screening recommendations have been further updated in recent years so that clinicians may help their patients to overcome the possible barriers in the context of risk discussion and motivate them to achieve their goals. In further detail, the contemporary algorithm deals with the following parameters: status of physical activity, the presence of any known cardiovascular, metabolic, or renal disease (CMRD), the presence of cardiac-related prodromal signs and symptoms, as well as the targeted exercise intensity to be achieved.[67] Nevertheless, screening methods for exercise-related cardiovascular safety for young competitive athletes (<35 years old) still remain controversial, while there is limited evidence regarding exercise recommendations in master athletes (>35 years old).[11]

So far, several international societies, such as the AHA, American College of Sports Medicine (ACSM), and ESC have proposed preparticipation survey questionnaires for health-fitness facilities to identify individuals at high risk of cardiovascular events during exercise,[20],[68] require medical assessment before entering a training program.[64] In more detail, the physical activity readiness questionnaire (PAR-Q) is widely used as a risk stratification and screening tool.[69],[70] It is estimated that 95.5% of women and 93.5% of men would ask for medical counseling before initiating an exercise program, as it was indicated by AHA/ACSM Preparticipation Questionnaire referral criteria.[70]

Similarly, the European Association of Preventive Cardiology (EAPC) recommends self-assessment by a brief questionnaire to determine if further evaluation and advice from health professionals are demanded.[71] Furthermore, evaluation of the individual likelihood of occult CVD is recommended by calculating the respective cardiovascular risk based on ESC Systematic Coronary Risk Evaluation (SCORE) risk charts, which include major risk factors of CVD, such as very high total cholesterol and low-density lipoprotein, diabetes mellitus, as well as family history of CVD.[72]

In this line, an electrocardiogram (ECG) allows to detect of occult cardiomyopathies and primary electrical disorders and may recognize subjects requiring additional testing (such as exercise testing) toward atherosclerotic CVD. Nevertheless, routine preparticipation ECG is an area of considerable debate. False-positive exercise testing results misclassify individuals as high risk, thus preventing them from physical activity and prompting further unnecessary invasive diagnostic procedures. Usually, ECG abnormalities among young athletes are attributed to increased vagal tone and specific exercise-related cardiac remodeling.[73] Although no further investigation is needed in most instances, the likelihood of abnormal cardiovascular substrate should be individually ruled out. In this context, professional societies have provided guidelines and specific criteria to avoid misinterpretation of ECG among individuals and, thus, false diagnoses.[74]

Notably, a review of randomized controlled trials of screening with exercise ECG indicated no improvement in health outcomes, although patients at high cardiovascular risk, such as those with diabetes mellitus, were included.[75] According to a relevant AHA/ACC scientific statement, screening with resting or exercise ECG testing is of unproven benefit in asymptomatic athletes or adults at low cardiovascular risk due to the high rates of false-positive results and prohibitive cost.[28],[76] Specifically, adding resting or exercise ECG to conventional risk factor assessment does not lead to improved risk stratification or decision-making in these patients. However, this recommendation contrasts with the position of ESC.[71] The European recommendation is based on an observational study, which was performed in Italy, where ECG preparticipation screening has been mandatory in athletes since 1982. Notably, this screening method led to a significant reduction in the annual incidence of sudden death among athletes 12–35 years by 89% (from 3.6 deaths to 0.4 deaths/100,000 athletes).[21] Thus, European guidelines suggest cardiac screening with family history, symptoms, physical examination, and 12-lead resting ECG as a preparticipation cardiovascular evaluation in healthy individuals aged >35 years who are about to initiate competitive sports (Class IIa).[11]

On the other hand, exercise testing seems to be a valuable tool for identifying potential cardiovascular abnormalities before starting an exercise program in the following cases: patients at high risk, such as high-risk middle-aged or older individuals, sedentary individuals with multiple risk factors for CVD, individuals who want to participate in high-intensity endurance sports, those with elevated coronary calcium (CAC) score, in those with a family history of premature CVD who wish to participate in vigorous training sessions, and most important in subjects who complain of cardiac symptoms or suffer from valvular heart disease.[77],[78] On the other hand, patients with structural and electrical disorders of the heart, such as Wolf-Parkinson-White, Brugada syndrome, and long-QT syndrome, require a detailed evaluation before engaging in any sports activity and a close follow-up by personnel with expertise in sports cardiology.[79]

Stress ECG and stress echocardiography are additional valuable tools for detecting obstructive CAD. However, exercise-related acute cardiovascular events might be provoked by nonocclusive atheromatic lesions via plenty of mechanisms, such as coronary vasospasm and plaque rapture,[58],[80] causing myocardial ischemia and life-threatening arrhythmogenesis.[5],[81] As a result, even coronary arteriography may not provide a definite diagnosis.[82] On the other hand, coronary calcification and atherosclerotic plaques are strong predictors for future cardiovascular morbidity and mortality. Coronary calcification has been associated with long-term cardiovascular events among marathoners.[83] Interestingly, cardiovascular event rates among marathon runners with CAC scores <100, 100–399, and ≥400 were 1.5, 12.0, and 21.4% (P = 0.002), respectively, after a median follow-up of 6 years. Indeed, coronary calcification (CAC score ≥100) seems to be more prevalent in athletes when compared to the controls, and more prominent in the most active, middle-aged or older athletes compared with the less active and younger athletes.[84] Furthermore, analysis of plaque morphology demonstrated fewer mixed plaques and, more often, only calcified plaques among athletes, thus revealing a milder composition of atherosclerotic plaque.[84] As a result, the assessment of atherosclerotic burden using the CAC score provides valuable information in terms of risk stratification. CAC scoring may be an option in asymptomatic athletes with a moderate atherosclerotic risk profile.[11] Moreover, according to recent data, optical coherence tomography (OCT) might be a useful imaging technique to unveil an alternative etiology of exercise-related ACS and SCD, among patients with nonobstructive CVD, also implying a tailored to the patient treatment.[85] In specific, OCT may depict plaque rupture or erosion, coronary dissection, and calcified nodule erosion among patients with nonsignificant stenotic coronary arteries who experienced exercise-triggered ACS or SCD.


  Cardiac Screening in Young Athletes and Healthy Adults before Participation in Sports Top


At present, there is little evidence to supp ort comprehensive cardiovascular screening for the prev ention of exercise-related acute cardiovascular events among young athletes. It should be, however, stressed that careful physical examination, along with personal and family medical history, remains the milestone for the identification of subjects at risk for SCD.[64],[73],[86] The role of ECG in risk stratification among young athletes is not universally supported (e.g. in the US) due to the already mentioned nonnegligible rate of false-positive results and financial reasons.[28],[71]

Similarly, current recommendations and evidence for cardiovascular screening efficacy in athletes >35 years of age are quite limited. Despite the higher prevalence of atherosclerotic CVD in this subgroup, routine screening for myocardial ischemia with exercise testing in asymptomatic adults is not recommended due to the low positive predictive value and high rates of false-positive results.[87],[88] In this context, exercise ECG testing is recommended only in symptomatic athletes or those at high risk of CAD based on the SCORE system.[71],[72] Moreover, exercise testing or cardiopulmonary exercise testing (CPET) is useful to evaluate cardiovascular performance among adults who start moderate-to-vigorous physical activity.[11] Currently, there is no evidence for incorporating routine cardiac imaging in preparticipation screening among asymptomatic individuals aged >35 years with a normal exercise stress test.[11] Individuals with symptoms suggesting myocardial ischemia, and abnormal findings on physical examination, ECG, or exercise stress test should be further investigated eventually with coronary angiography according to ESC guidelines for chronic coronary syndromes (CCS).


  Cardiac Screening in Patients with Cardiovascular Disease before Participation in Sports Top


Exercise testing, despite its lower specificity for myocardial ischemia compared to other functional tests, is the most widely available tool with the ability to provide valuable information on exercise capacity, heart rate, blood pressure response, and detection of exercise-induced arrhythmias, especially in asymptomatic and low-risk individuals.[13] According to ESC guidelines, risk stratification for exercise-induced adverse events is recommended in individuals with the established CCS before engaging in exercise.[11] In case of borderline test results, more specific imaging stress tests such as stress-echocardiography, cardiac CMR, or single-photon emission computed tomography should be performed. Moreover, patients with heart failure (HF) who wish to participate in cardiac rehabilitation training programs should undergo a comprehensive cardiological evaluation, including measurement of blood natriuretic peptides, the performance of echocardiography and maximal exercise test, preferably CPET, to assess functional capacity, exercise-induced arrhythmias or hemodynamic abnormalities.[11],[89] In the latter patients, before considering sports activities, a preliminary optimization of HF risk factor control and therapy, including device implantation, if appropriate, is recommended.[11]

A comprehensive cardiological evaluation is also required in patients with HCM who wish to engage in sports activities. Baseline preparticipation assessment includes a detailed personal and family history taking into account age, level of exercise before diagnosis, assessment of the severity of the HCM phenotype, and the presence of conventional risk factors for SCD. In this context, 12-lead resting ECG or even preferably 48-h ECG, echocardiography, CMR imaging, and exercise testing or CPET are extremely helpful for risk stratification.[11]

Finally, precise recommendations for exercise screening and participation in sports for patients with HF with preserved or reduced ejection fraction, valvular disease, ACS, heart transplantation, arrhythmogenic or dilated cardiomyopathy, myocarditis, pericarditis, cardiac arrhythmias, channelopathies as well as adult congenital heart disease have also been reported in the 2020 ESC Guidelines on Sports Cardiology and Exercise.[11],[90]

Regarding exercise intensity, it is well established that vigorous physical activity increases the risk of acute cardiovascular events and among patients with known or occult CVD, when compared to mild-to-moderate-intensity training.[87] Therefore, cardiovascular screening restricts high-risk patients from rigorous activities. Nevertheless, these patients should be encouraged to participate in moderate training programs, to prevent obesity and atherosclerosis, with the final goal to reduce the individual future cardiac risk.[64]

According to ESC, individuals who are physically active and at low or moderate risk, based on SCORE charts, are allowed to participate in all exercise training programs without restrictions, including competitive sports.[90] Nevertheless, individuals following a sedentary lifestyle or at high or very high CVD risk (SCORE ≥5%) are eligible to participate in low-intensity exercise without further evaluation; otherwise, they should undergo a physical examination, 12-lead resting ECG, exercise stress test and on an individual basis functional imaging test or coronary computed tomography angiography before engaging in high-intensity training sessions.[90],[91] Furthermore, patients with chronic HF should be excluded from exercise programs in case of arterial hypotension or hypertension at rest or during exercise, unstable cardiac disease, deteriorating symptoms of HF, myocardial ischemia despite therapy, or severe and suboptimally treated pulmonary disease.


  Education of Fitness Personnel and Facilities for Cardiovascular Emergencies Top


Exercise-triggered cardiovascular events and death rates might be decreased if the personnel are well instructed and training facilities are well prepared to manage cardiovascular emergencies. Professional organizations recommend that coaches and trainers involved in exercise programs should be certified in cardiopulmonary resuscitation and be instructed to handle medical emergencies.[92] Moreover, the availability of automated external defibrillators in all fitness facilities has been strongly emphasized.[93],[94],[95] In addition, health-fitness facilities should perform pre-entry screening, have written emergency policies, conduct regular emergency drills and cardiopulmonary resuscitation, as well as establish a “hotline” for immediate use in case of medical emergencies.[20]

Unfortunately, it seems that there is a significant gap between international guidelines and everyday practice. It has been reported that plenty of health clubs demonstrate low compliance with national standards, thus being unprepared for cardiovascular complications.[96] In particular, failures in pre-entry cardiac screening procedures and in emergency response drills, as well as the absence of written emergency response plans and automated external defibrillators, have been detected. Therefore, healthcare facilities should offer educational seminars to their staff regarding the management of cardiac emergencies and dispose of a specified plan in such cases, along with adequate resuscitation equipment.


  Prudence of Exercise Top


The abrupt and intense physical effort seems to increase the risk of cardiac ischemia and SCD, while sudden cessation of physical activity tends to decrease central blood volume and arterial pressure.[97],[98] Thus, exercising individuals, and especially patients with established CVD, are advised to perform at least 5 min each of warm-up and cool-down in their training sessions. Furthermore, vigorous exercise in extremely cold temperatures, such as snow shoveling, has been strongly associated with a higher risk of acute cardiovascular events.[99] In contrast, individuals exercising in hot and humid environments depict high heart rates as a response to the increased thermal load, which in turn increases myocardial oxygen demands.[100] Accordingly, physically inactive individuals and patients with established CVD should be advised against participation in vigorous fitness programs in either extremely cold or hot environmental conditions.[20] Moreover, high altitude reduces oxygen availability, activates the sympathetic system, and increases cardiorespiratory demands.[101],[102],[103] Therefore, individuals exercising at an altitude above 1500 m should be aware of their exercise intensity goals, following a more prudent training policy. In summary, patients with established CVD that wish to participate in competitive sports should seek medical counseling by high-experienced physicians and specialists in sports cardiology based on AHA/ACC eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities.[73],[101],[104]

Physically inactive individuals with or without CVD are encouraged to participate regularly in training fitness programs but to gradually achieve their exercise target goal. Considering that less active individuals are at higher risk for exercise-triggered cardiovascular events, beginners should exercise slowly and then increase gradually exercise intensity and duration, if tolerated, to avoid cardiac fatalities.[105] Furthermore, previously inactive patients with or without CVD should avoid vigorous physical activity, such as racquet sport and snow removal.[106],[107] Finally, cardiac rehabilitation centers, where physicians work in partnership with their patients, offer behavioral health modification, adherence to medical treatment as well as structured and supervised training facilities, thus promoting cardiovascular health. Therefore, patients are highly encouraged to participate in the available certified programs.[108]


  Adherence to Exercise Top


Healthy lifestyles and behavioral modification are of major importance not only for the prevention but also for the management of CVD. Adherence to regular exercise significantly improves recurrent cardiovascular events, as well as complications following an ACS. Interestingly, patients with a history of recent ACS, who report non-adherence to exercise, diet, and persistent tobacco use, seem to have a 3.8-fold increased risk of MI, stroke, or death compared to those that comply with the behavioral advice.[109] Despite the strong recommendations of international guidelines, a large majority of patients with CVD follow an unhealthy lifestyle, which prevents them from achieving the previously-reported target goals for secondary prevention after a cardiovascular event.[110] Adherence to exercise may lead to a reduction in all major events by 50%, 6 months after an ACS. Therefore, initiating and maintaining a physically active lifestyle, and especially adherence to the long-term exercise training programs, among patients with CVD and/or comorbid conditions, remains a real challenge for both physicians and patients.[111]

In specific, exercise adherence seems to decrease substantially during these patients' long-term follow-up.[112] Lack of compliance is mainly attributed to several factors, such as disease-associated limitations, multiple comorbidities, and absence of motivation. According to recent data, patients after an ACS are more likely to drop out of physical activity schedule, usually within 6 months after hospital discharge,[113] while older age,[114] female sex,[115] and high body mass index (BMI),[110] have been strongly correlated to physical inactivity. Interestingly, 38% of patients after an ACS fails to maintain adequate physical activity over time.[116] Thus, clinicians should pay additional attention and optimize their efforts to patients who are less willing to change their behavioral lifestyles, such as the elderly, women, and those with obesity, as well as encourage them to participate in structured exercise training intervention programs, to achieve an adequate level of cardiorespiratory fitness.

Although some authors support that the use of aspirin and/or b-blocker may be beneficial for patients at high risk of CVD before initiating competitive exercise,[117],[118] there is no strong evidence that these medications prevent exercise-triggered acute cardiovascular events. Therefore, due to scant data availability, prophylactic use of the latter medications is not routinely recommended before vigorous physical activity or sports participation, while proper discussion and shared decision-making between clinicians and patients are highly encouraged.[64]

At present, it is speculated that “the more exercise training is always, the better,”[77] while marathon running may offer immunity to CVD.[119] Half and full marathon races, as well as triathlon events, have gained plenty of popularity, and number of athletes practicing these sports increased rapidly during the past decades. Nevertheless, reports of marathon runners dying during races are coming to the public's attention due to known or occult CVD, in combination with extreme physical and environmental conditions such as cold, heat, and humidity.[120] It seems that inadequate preparation or poor training is strongly correlated with exercise-related fatalities.[121] Moreover, sprinting during the final miles has been associated with a greater risk of acute cardiovascular events,[62] and as a result, competitors at high risk or cardiac events should be advised to maintain stability in their running through the whole race. Therefore, personalized counseling and appropriate management are of great importance.


  Novel Prevention Strategies Top


It is quite challenging for physicians to implement guidelines into everyday clinical practice based on patients' cardiovascular profiles and needs. As far as exercise training programs are concerned, exercise prescription for an individual is even more tricky since international recommendations should combine a patient's cardiovascular history along with concomitant medications and the presence of comorbidities. Indeed, remarkable technological progress in the field of personalized medicine provides novel tools who may also apply in the context of Sports Cardiology.

The EAPC exercise prescription in everyday practice and rehabilitative training (EXPERT) tool is an interactive, digital training and support system, which aims to help not exclusively cardiovascular rehabilitation or sports medicine specialists but also family physicians, cardiologists, and other medical specialties, to prescribe clinically effective and medically safe exercise training programs among patients with CVD.[122] This website application offers health-care professionals the chance to choose and implement the most optimal and effective exercise training program for each patient. However, a structured setting, along with skilled and licensed supervisors, should be guaranteed to reach the desired cardiorespiratory outcomes, diminishing the risk of cardiac-related adverse events.

In further detail, the “EXPERT” is a 4-step process. Initially, patient characteristics, based on clinical examination and laboratory findings, should be entered as parameters into the online platform. The next step is to select the presence of CVD, as well as risk factors for CVD when present. Specific contaminant medications that might interfere with the exercise training procedure, such as b-blockers, statins, insulin administration, and other anti-diabetic agents, are taken into account. Furthermore, exercise-related adverse cardiovascular events, such as myocardial ischemia, cardiac arrhythmias, or the presence of ICD, are also addressed. Finally, the “EXPERT” tool will generate the most-appropriate exercise training program for each patient, discouraging certain types of exercise and providing individualized safety advice.[122] Interestingly, personalized recommendations regarding exercise training intensity, frequency duration, type, session, as well as additional exercise training modalities will be provided. Thus, guided, detailed, and comprehensive exercise prescription is easily accessible to physicians and patients, thus achieving better treatment and outcomes.


  How Can the Guidelines Guide Us? Top


Both improving exercise capacity and optimizing the safety of cardiorespiratory training programs play a major role in promoting cardiovascular health. Thus, international organizations, professional societies, health-care professionals, and policy makers show an upgrowing interest in exercise-derived cardiovascular benefits, providing systemic recommendations as well as prevention strategies, as presented in [Figure 1]. According to the 2019 ACC/AHA Guideline on the Primary Prevention of CVD, in general, healthy individuals should undergo at least 150 min/week of accumulated moderate-intensity physical activity. Otherwise, 75 min/week of vigorous-intensity physical activity to reduce the risk of atherosclerotic CVD.[123] In agreement with the previous recommendations, ESC suggests that additional benefit is achieved by doubling the previous exercise duration, with multiple sessions of exercise carried out throughout the week.[11],[72] In case that individuals are unable to comply with the previous recommendation, participation in moderate or vigorous-intensity physical activity, even below the target goal, might also be beneficial for the cardiovascular system.
Figure 1: Prevention strategies for exercise-related acute cardiovascular events

Click here to view


Furthermore, it is of major importance that health-care professionals provide patient-focused counseling to help them optimize their physical activity status.[123] In particular, physically active asymptomatic individuals without known CMRD may continue their usual moderate or vigorous exercise and progress gradually as tolerated, while those with CMRD who have been medically evaluated the previous year, may continue a moderate-intensity exercise program.[64],[124] On the other hand, physically inactive individuals without known CMRD may begin mild-to-moderate-intensity exercise without medical guidance, and if they remain asymptomatic, progress gradually in intensity, while those with known CMRD or suggestive should seek medical guidance before starting an exercise program, regardless of the intensity[18],[80],[64],[124] Although the exercise-related health benefits outweigh the potential cardiovascular risks, individuals who develop signs or symptoms during exercise should immediately discontinue training sessions and seek medical care before resuming the exercise of any intensity.[124]

In addition, prescription of exercise and easy access to well-structured and fully-organized training facilities for physical activity are also recommended.[123] Exercise-based cardiac rehabilitation is recommended in all individuals with CAD to reduce cardiac mortality and rehospitalization, while participation in competitive sports is not recommended in individuals with CCS, at high risk for exercise-induced adverse events or those with residual ischemia. In addition, exercise-based cardiac rehabilitation is recommended in all stable individuals with HF to improve exercise capacity and quality of life and to reduce the rate of hospital readmission.[11] As far as HCM is concerned, participation in high-intensity exercise (including recreational and competitive sports) is not recommended in high-risk individuals.[11] Finally, as already mentioned, individuals with congenital or structural cardiovascular abnormalities should ask for specialized counseling by highly experienced physicians and avoid engagement in highly competitive or vigorous endurance training sessions in the absence of medical guidance, whereas leisure-time or low-to-moderate-intensity physical activity might be more appropriate in this setting.[77]


  Conclusions Top


A healthy lifestyle, and especially exercise training, throughout life, is the cornerstone for the prevention of atherosclerotic CVD. Notably, exercise training enhances functional capacity, muscle strength and endurance, quality of life, and cardiac-related biomarkers, thus improving significantly cardiovascular risk and survival rates. According to evidence-based recommendations for the prevention of CVD, a comprehensive and more personalized approach should be applied, taking into account the individual behavioral habits and estimated risk of future cardiovascular events. Detailed strategies should be catholically applied both in young or older athletes, patients with established CVD or risk factors for CVD in order to prevent exercise-triggered cardiovascular events. Participation in structured programs for therapy optimization and adherence, and risk factor modification, including exercise training and smoke cessation, improves the quality of care and is highly recommended to patients with established CVD or risk factors for CVD. Health-care providers should not overestimate the risks of exercise since the exercise-related cardiovascular benefit outweighs significantly any potential harms. The rule of “Primum Non-Nocere” should always be applied when an exercise program is advised.

Ethical Statement

The ethical statement is not applicable for this article.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Blair SN, Kohl HW 3rd, Paffenbarger RS Jr., Clark DG, Cooper KH, Gibbons LW. Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA 1989;262:2395-401.  Back to cited text no. 1
    
2.
Thompson PD, Buchner D, Pina IL, Balady GJ, Williams MA, Marcus BH, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: A statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation 2003;107:3109-16.  Back to cited text no. 2
    
3.
Winzer EB, Woitek F, Linke A. Physical activity in the prevention and treatment of coronary artery disease. J Am Heart Assoc 2018;7:e007725.  Back to cited text no. 3
    
4.
von Klot S, Mittleman MA, Dockery DW, Heier M, Meisinger C, Hörmann A, et al. Intensity of physical exertion and triggering of myocardial infarction: A case-crossover study. Eur Heart J 2008;29:1881-8.  Back to cited text no. 4
    
5.
Albert CM, Mittleman MA, Chae CU, Lee IM, Hennekens CH, Manson JE. Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med 2000;343:1355-61.  Back to cited text no. 5
    
6.
Harmon KG, Asif IM, Maleszewski JJ, Owens DS, Prutkin JM, Salerno JC, et al. Incidence, cause, and comparative frequency of sudden cardiac death in National Collegiate Athletic Association athletes: A decade in review. Circulation 2015;132:10-9.  Back to cited text no. 6
    
7.
Maron BJ, Roberts WC, McAllister HA, Rosing DR, Epstein SE. Sudden death in young athletes. Circulation 1980;62:218-29.  Back to cited text no. 7
    
8.
Sudden Death in Young Athletes | Annals of Internal Medicine. Available from: https://www.acpjournals.org/doi/epdf/10.7326/0003-4819-67-5-1013. [Last accessed on 2022 May 15].  Back to cited text no. 8
    
9.
Outcomes of Cardiac Screening in Adolescent Soccer Players | NEJM. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa1714719. [Last accessed on 2022 May 18].  Back to cited text no. 9
    
10.
Recommendations for Competitive Sports Participation in Athletes with Cardiovascular Disease: A Consensus Document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology – PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/15923204/. [Last accessed on 2022 May 15].  Back to cited text no. 10
    
11.
Pelliccia A, Sharma S, Gati S, Bäck M, Börjesson M, Caselli S, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J 2021;42:17-96.  Back to cited text no. 11
    
12.
Pelliccia A, Solberg EE, Papadakis M, Adami PE, Biffi A, Caselli S, et al. Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: Position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC). Eur Heart J 2019;40:19-33.  Back to cited text no. 12
    
13.
Börjesson M, Dellborg M. Exercise testing post-MI: Still worthwhile in the interventional era. Eur Heart J 2005;26:105-6.  Back to cited text no. 13
    
14.
Solberg EE, Borjesson M, Sharma S, Papadakis M, Wilhelm M, Drezner JA, et al. Sudden cardiac arrest in sports – Need for uniform registration: A Position Paper from the Sport Cardiology Section of the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Prev Cardiol 2016;23:657-67.  Back to cited text no. 14
    
15.
Maron BJ, Thompson PD, Ackerman MJ, Balady G, Berger S, Cohen D, et al. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: A scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: Endorsed by the American College of Cardiology Foundation. Circulation 2007;115:1643-455.  Back to cited text no. 15
    
16.
Drezner JA, Peterson DF, Siebert DM, Thomas LC, Lopez-Anderson M, Suchsland MZ, et al. Survival after exercise-related sudden cardiac arrest in young athletes: Can we do better? Sports Health 2019;11:91-8.  Back to cited text no. 16
    
17.
McKinney J, Velghe J, Fee J, Isserow S, Drezner JA. Defining athletes and exercisers. Am J Cardiol 2019;123:532-5.  Back to cited text no. 17
    
18.
Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DR Jr., Tudor-Locke C, et al. 2011 Compendium of Physical Activities: A second update of codes and MET values. Med Sci Sports Exerc 2011;43:1575-81.  Back to cited text no. 18
    
19.
Hootman JM. 2008 Physical Activity Guidelines for Americans: An opportunity for athletic trainers. J Athl Train 2009;44:5-6.  Back to cited text no. 19
    
20.
Thompson PD, Franklin BA, Balady GJ, Blair SN, Corrado D, Estes NA 3rd, et al. Exercise and acute cardiovascular events placing the risks into perspective: A scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology. Circulation 2007;115:2358-68.  Back to cited text no. 20
    
21.
Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 2006;296:1593-601.  Back to cited text no. 21
    
22.
Drezner JA, O'Connor FG, Harmon KG, Fields KB, Asplund CA, Asif IM, et al. AMSSM Position Statement on cardiovascular preparticipation screening in athletes: Current evidence, knowledge gaps, recommendations, and future directions. Clin J Sport Med 2016;26:347-61.  Back to cited text no. 22
    
23.
Maron BJ, Zipes DP, Kovacs RJ; American Heart Association Electrocardiography and Arrhythmias Committee of Council on Clinical Cardiology, Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and American College of Cardiology. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Preamble, principles, and general considerations: A scientific statement from the American Heart Association and American College of Cardiology. Circulation 2015;132:e256-61.  Back to cited text no. 23
    
24.
Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA 1996;276:199-204.  Back to cited text no. 24
    
25.
Burke AP, Farb A, Malcom GT, Liang Y, Smialek JE, Virmani R. Plaque rupture and sudden death related to exertion in men with coronary artery disease. JAMA 1999;281:921-6.  Back to cited text no. 25
    
26.
Maron BJ, Haas TS, Murphy CJ, Ahluwalia A, Rutten-Ramos S. Incidence and causes of sudden death in U.S. college athletes. J Am Coll Cardiol 2014;63:1636-43.  Back to cited text no. 26
    
27.
Semsarian C, Ingles J, Wilde AA. Sudden cardiac death in the young: The molecular autopsy and a practical approach to surviving relatives. Eur Heart J 2015;36:1290-6.  Back to cited text no. 27
    
28.
Maron BJ, Friedman RA, Kligfield P, Levine BD, Viskin S, Chaitman BR, et al. Assessment of the 12-lead ECG as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 Years of Age): A scientific statement from the American Heart Association and the American College of Cardiology. Circulation 2014;130:1303-34.  Back to cited text no. 28
    
29.
Maron BJ, Haas TS, Ahluwalia A, Murphy CJ, Garberich RF. Demographics and epidemiology of sudden deaths in young competitive athletes: From the United States National Registry. Am J Med 2016;129:1170-7.  Back to cited text no. 29
    
30.
Authors/Task Force members, Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014;35:2733-79.  Back to cited text no. 30
    
31.
Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011;124:e783-831.  Back to cited text no. 31
    
32.
Sheikh N, Papadakis M, Schnell F, Panoulas V, Malhotra A, Wilson M, et al. Clinical profile of athletes with hypertrophic cardiomyopathy. Circ Cardiovasc Imaging 2015;8:e003454.  Back to cited text no. 32
    
33.
Pelliccia A, Maron BJ, Spataro A, Proschan MA, Spirito P. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med 1991;324:295-301.  Back to cited text no. 33
    
34.
Caselli S, Maron MS, Urbano-Moral JA, Pandian NG, Maron BJ, Pelliccia A. Differentiating left ventricular hypertrophy in athletes from that in patients with hypertrophic cardiomyopathy. Am J Cardiol 2014;114:1383-9.  Back to cited text no. 34
    
35.
Maron BJ. Hypertrophic cardiomyopathy: A systematic review. JAMA 2002;287:1308-20.  Back to cited text no. 35
    
36.
Moore B, Semsarian C, Chan KH, Sy RW. Sudden cardiac death and ventricular arrhythmias in hypertrophic cardiomyopathy. Heart Lung Circ 2019;28:146-54.  Back to cited text no. 36
    
37.
Schumacher B, Gietzen FH, Neuser H, Schümmelfeder J, Schneider M, Kerber S, et al. Electrophysiological characteristics of septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy and moderate to severe symptoms. Circulation 2005;112:2096-101.  Back to cited text no. 37
    
38.
Siontis KC, Ommen SR, Geske JB. Sex, survival, and cardiomyopathy: Differences between men and women with hypertrophic cardiomyopathy. J Am Heart Assoc 2019;8:e014448.  Back to cited text no. 38
    
39.
Dejgaard LA, Haland TF, Lie OH, Ribe M, Bjune T, Leren IS, et al. Vigorous exercise in patients with hypertrophic cardiomyopathy. Int J Cardiol 2018;250:157-63.  Back to cited text no. 39
    
40.
Lampert R, Olshansky B, Heidbuchel H, Lawless C, Saarel E, Ackerman M, et al. Safety of sports for athletes with implantable cardioverter-defibrillators: Long-term results of a prospective multinational registry. Circulation 2017;135:2310-2.  Back to cited text no. 40
    
41.
Ellison SR. Sudden cardiac death in adolescents. Prim Care 2015;42:57-76.  Back to cited text no. 41
    
42.
Basso C, Maron BJ, Corrado D, Thiene G. Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. J Am Coll Cardiol 2000;35:1493-501.  Back to cited text no. 42
    
43.
Gati S, Malhotra A, Sharma S. Exercise recommendations in patients with valvular heart disease. Heart 2019;105:106-10.  Back to cited text no. 43
    
44.
Basso C, Perazzolo Marra M, Rizzo S, De Lazzari M, Giorgi B, Cipriani A, et al. Arrhythmic mitral valve prolapse and sudden cardiac death. Circulation 2015;132:556-66.  Back to cited text no. 44
    
45.
Basso C, Iliceto S, Thiene G, Perazzolo Marra M. Mitral valve prolapse, ventricular arrhythmias, and sudden death. Circulation 2019;140:952-64.  Back to cited text no. 45
    
46.
Perazzolo Marra M, Basso C, De Lazzari M, Rizzo S, Cipriani A, Giorgi B, et al. Morphofunctional abnormalities of mitral annulus and arrhythmic mitral valve prolapse. Circ Cardiovasc Imaging 2016;9:e005030.  Back to cited text no. 46
    
47.
Maron BJ. Cardiovascular risks to young persons on the athletic field. Ann Intern Med 1998;129:379-86.  Back to cited text no. 47
    
48.
Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002;106:69-74.  Back to cited text no. 48
    
49.
Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, et al. Risk stratification in the long-QT syndrome. N Engl J Med 2003;348:1866-74.  Back to cited text no. 49
    
50.
Brugada J, Brugada R, Antzelevitch C, Towbin J, Nademanee K, Brugada P. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation 2002;105:73-8.  Back to cited text no. 50
    
51.
Wellens HJ, Rodriguez LM, Timmermans C, Smeets JP. The asymptomatic patient with the Wolff-Parkinson-White electrocardiogram. Pacing Clin Electrophysiol 1997;20:2082-6.  Back to cited text no. 51
    
52.
Burke AP, Subramanian R, Smialek J, Virmani R. Nonatherosclerotic narrowing of the atrioventricular node artery and sudden death. J Am Coll Cardiol 1993;21:117-22.  Back to cited text no. 52
    
53.
Finocchiaro G, Papadakis M, Robertus JL, Dhutia H, Steriotis AK, Tome M, et al. Etiology of sudden death in sports: Insights from a United Kingdom Regional Registry. J Am Coll Cardiol 2016;67:2108-15.  Back to cited text no. 53
    
54.
Harmon KG, Drezner JA, Maleszewski JJ, Lopez-Anderson M, Owens D, Prutkin JM, et al. Pathogeneses of sudden cardiac death in national collegiate athletic association athletes. Circ Arrhythm Electrophysiol 2014;7:198-204.  Back to cited text no. 54
    
55.
Eckart RE, Shry EA, Burke AP, McNear JA, Appel DA, Castillo-Rojas LM, et al. Sudden death in young adults: An autopsy-based series of a population undergoing active surveillance. J Am Coll Cardiol 2011;58:1254-61.  Back to cited text no. 55
    
56.
Marijon E, Tafflet M, Celermajer DS, Dumas F, Perier MC, Mustafic H, et al. Sports-related sudden death in the general population. Circulation 2011;124:672-81.  Back to cited text no. 56
    
57.
Siscovick DS, Weiss NS, Fletcher RH, Lasky T. The incidence of primary cardiac arrest during vigorous exercise. N Engl J Med 1984;311:874-7.  Back to cited text no. 57
    
58.
Mittleman MA, Maclure M, Tofler GH, Sherwood JB, Goldberg RJ, Muller JE. Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of Myocardial Infarction Onset Study Investigators. N Engl J Med 1993;329:1677-83.  Back to cited text no. 58
    
59.
Corrado D, Migliore F, Basso C, Thiene G. Exercise and the risk of sudden cardiac death. Herz 2006;31:553-8.  Back to cited text no. 59
    
60.
Kim JH, Malhotra R, Chiampas G, d'Hemecourt P, Troyanos C, Cianca J, et al. Cardiac arrest during long-distance running races. N Engl J Med 2012;366:130-40.  Back to cited text no. 60
    
61.
Chugh SS, Weiss JB. Sudden cardiac death in the older athlete. J Am Coll Cardiol 2015;65:493-502.  Back to cited text no. 61
    
62.
Redelmeier DA, Greenwald JA. Competing risks of mortality with marathons: Retrospective analysis. BMJ 2007;335:1275-7.  Back to cited text no. 62
    
63.
Maron BJ, Epstein SE, Roberts WC. Causes of sudden death in competitive athletes. J Am Coll Cardiol 1986;7:204-14.  Back to cited text no. 63
    
64.
Franklin BA, Thompson PD, Al-Zaiti SS, Albert CM, Hivert MF, Levine BD, et al. Exercise-related acute cardiovascular events and potential deleterious adaptations following long-term exercise training: Placing the risks into perspective-an update: A scientific statement from the American Heart Association. Circulation 2020;141:e705-36.  Back to cited text no. 64
    
65.
Goodman JM, Burr JF, Banks L, Thomas SG. The acute risks of exercise in apparently healthy adults and relevance for prevention of cardiovascular events. Can J Cardiol 2016;32:523-32.  Back to cited text no. 65
    
66.
Malhotra A, Dhutia H, Finocchiaro G, Gati S, Beasley I, Clift P, et al. Outcomes of cardiac screening in adolescent soccer players. N Engl J Med 2018;379:524-34.  Back to cited text no. 66
    
67.
Armstrong M, Paternostro-Bayles M, Conroy MB, Franklin BA, Richardson C, Kriska A. Preparticipation screening prior to physical activity in community lifestyle interventions. Transl J Am Coll Sports Med 2018;3:176-80.  Back to cited text no. 67
    
68.
Balady GJ, Chaitman B, Driscoll D, Foster C, Froelicher E, Gordon N, et al. Recommendations for cardiovascular screening, staffing, and emergency policies at health/fitness facilities. Circulation 1998;97:2283-93.  Back to cited text no. 68
    
69.
Shephard RJ. Qualified fitness and exercise as professionals and exercise prescription: Evolution of the PAR-Q and Canadian Aerobic Fitness Test. J Phys Act Health 2015;12:454-61.  Back to cited text no. 69
    
70.
Whitfield GP, Pettee Gabriel KK, Rahbar MH, Kohl HW 3rd. Application of the American Heart Association/American College of Sports Medicine Adult Preparticipation Screening Checklist to a nationally representative sample of US adults aged >=40 years from the National Health and Nutrition Examination Survey 2001 to 2004. Circulation 2014;129:1113-20.  Back to cited text no. 70
    
71.
Mont L, Pelliccia A, Sharma S, Biffi A, Borjesson M, Brugada Terradellas J, et al. Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE. Eur J Prev Cardiol 2017;24:41-69.  Back to cited text no. 71
    
72.
Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016;37:2315-81.  Back to cited text no. 72
    
73.
Maron BJ, Levine BD, Washington RL, Baggish AL, Kovacs RJ, Maron MS, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task force 2: Preparticipation screening for cardiovascular disease in competitive athletes: A scientific statement from the American Heart Association and American College of Cardiology. Circulation 2015;132:e267-72.  Back to cited text no. 73
    
74.
Hyde N, Prutkin JM, Drezner JA. Electrocardiogram interpretation in NCAA athletes: Comparison of the “Seattle” and “International” criteria. J Electrocardiol 2019;56:81-4.  Back to cited text no. 74
    
75.
Jonas DE, Reddy S, Middleton JC, Barclay C, Green J, Baker C, et al. Screening for cardiovascular disease risk with resting or exercise electrocardiography: Evidence report and systematic review for the US Preventive Services Task Force. JAMA 2018;319:2315-28.  Back to cited text no. 75
    
76.
US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, et al. Screening for cardiovascular disease risk with electrocardiography: US Preventive Services Task Force Recommendation Statement. JAMA 2018;319:2308-14.  Back to cited text no. 76
    
77.
Sanchis-Gomar F, Santos-Lozano A, Garatachea N, Pareja-Galeano H, Fiuza-Luces C, Joyner MJ, et al. My patient wants to perform strenuous endurance exercise. What's the right advice? Int J Cardiol 2015;197:248-53.  Back to cited text no. 77
    
78.
Nasir K, Rubin J, Blaha MJ, Shaw LJ, Blankstein R, Rivera JJ, et al. Interplay of coronary artery calcification and traditional risk factors for the prediction of all-cause mortality in asymptomatic individuals. Circ Cardiovasc Imaging 2012;5:467-73.  Back to cited text no. 78
    
79.
Mascia G, Arbelo E, Hernandez-Ojeda J, Solimene F, Brugada R, Brugada J. Brugada syndrome and exercise practice: Current knowledge, shortcomings and open questions. Int J Sports Med 2017;38:e2.  Back to cited text no. 79
    
80.
Giri S, Thompson PD, Kiernan FJ, Clive J, Fram DB, Mitchel JF, et al. Clinical and angiographic characteristics of exertion-related acute myocardial infarction. JAMA 1999;282:1731-6.  Back to cited text no. 80
    
81.
Ashley EA, Myers J, Froelicher V. Exercise testing in clinical medicine. Lancet 2000;356:1592-7.  Back to cited text no. 81
    
82.
Roe MT, Harrington RA, Prosper DM, Pieper KS, Bhatt DL, Lincoff AM, et al. Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease. The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators. Circulation 2000;102:1101-6.  Back to cited text no. 82
    
83.
Möhlenkamp S, Leineweber K, Lehmann N, Braun S, Roggenbuck U, Perrey M, et al. Coronary atherosclerosis burden, but not transient troponin elevation, predicts long-term outcome in recreational marathon runners. Basic Res Cardiol 2014;109:391.  Back to cited text no. 83
    
84.
Aengevaeren VL, Mosterd A, Sharma S, Prakken NH, Möhlenkamp S, Thompson PD, et al. Exercise and coronary atherosclerosis: Observations, explanations, relevance, and clinical management. Circulation 2020;141:1338-50.  Back to cited text no. 84
    
85.
Mas-Lladó C, Maristany J, Gómez-Lara J, Pascual M, Alameda MD, Gómez-Jaume A, et al. Optical coherence tomography for the diagnosis of exercise-related acute cardiovascular events and inconclusive coronary angiography. J Interv Cardiol 2020;2020:8263923.  Back to cited text no. 85
    
86.
Landry CH, Allan KS, Connelly KA, Cunningham K, Morrison LJ, Dorian P, et al. Sudden cardiac arrest during participation in competitive sports. N Engl J Med 2017;377:1943-53.  Back to cited text no. 86
    
87.
Fletcher GF, Ades PA, Kligfield P, Arena R, Balady GJ, Bittner VA, et al. Exercise standards for testing and training: A scientific statement from the American Heart Association. Circulation 2013;128:873-934.  Back to cited text no. 87
    
88.
Corrado D, Schmied C, Basso C, Borjesson M, Schiavon M, Pelliccia A, et al. Risk of sports: Do we need a pre-participation screening for competitive and leisure athletes? Eur Heart J 2011;32:934-44.  Back to cited text no. 88
    
89.
Corrà U, Agostoni PG, Anker SD, Coats AJ, Crespo Leiro MG, de Boer RA, et al. Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2018;20:3-15.  Back to cited text no. 89
    
90.
Budts W, Pieles GE, Roos-Hesselink JW, Sanz de la Garza M, D'Ascenzi F, Giannakoulas G, et al. Recommendations for participation in competitive sport in adolescent and adult athletes with Congenital Heart Disease (CHD): Position statement of the Sports Cardiology & Exercise Section of the European Association of Preventive Cardiology (EAPC), the European Society of Cardiology (ESC) Working Group on Adult Congenital Heart Disease and the Sports Cardiology, Physical Activity and Prevention Working Group of the Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2020;41:4191-9.  Back to cited text no. 90
    
91.
Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020;41:407-77.  Back to cited text no. 91
    
92.
Maron BJ, Thompson PD, Puffer JC, McGrew CA, Strong WB, Douglas PS, et al. Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. Circulation 1996;94:850-6.  Back to cited text no. 92
    
93.
Drezner JA, Asif IM, Harmon KG. Automated external defibrillators in health and fitness facilities. Phys Sportsmed 2011;39:114-8.  Back to cited text no. 93
    
94.
Kinoshi T, Tanaka S, Sagisaka R, Hara T, Shirakawa T, Sone E, et al. Mobile automated external defibrillator response system during road races. N Engl J Med 2018;379:488-9.  Back to cited text no. 94
    
95.
Blom MT, Beesems SG, Homma PC, Zijlstra JA, Hulleman M, van Hoeijen DA, et al. Improved survival after out-of-hospital cardiac arrest and use of automated external defibrillators. Circulation 2014;130:1868-75.  Back to cited text no. 95
    
96.
McInnis K, Herbert W, Herbert D, Herbert J, Ribisl P, Franklin B. Low compliance with national standards for cardiovascular emergency preparedness at health clubs. Chest 2001;120:283-8.  Back to cited text no. 96
    
97.
Barnard RJ, MacAlpin R, Kattus AA, Buckberg GD. Ischemic response to sudden strenuous exercise in healthy men. Circulation 1973;48:936-42.  Back to cited text no. 97
    
98.
Barnard RJ, Gardner GW, Diaco NV, MacAlpin RN, Kattus AA. Cardiovascular responses to sudden strenuous exercise-heart rate, blood pressure, and ECG. J Appl Physiol 1973;34:833-7.  Back to cited text no. 98
    
99.
Hammoudeh AJ, Haft JI. Coronary-plaque rupture in acute coronary syndromes triggered by snow shoveling. N Engl J Med 1996;335:2001.  Back to cited text no. 99
    
100.
Pandolf KB, Cafarelli E, Noble BJ, Metz KF. Hyperthermia: Effect on exercise prescription. Arch Phys Med Rehabil 1975;56:524-6.  Back to cited text no. 100
    
101.
Levine BD, Zuckerman JH, deFilippi CR. Effect of high-altitude exposure in the elderly: The Tenth Mountain Division study. Circulation 1997;96:1224-32.  Back to cited text no. 101
    
102.
Levine BD. Going high with heart disease: The effect of high altitude exposure in older individuals and patients with coronary artery disease. High Alt Med Biol 2015;16:89-96.  Back to cited text no. 102
    
103.
Lo MY, Daniels JD, Levine BD, Burtscher M. Sleeping altitude and sudden cardiac death. Am Heart J 2013;166:71-5.  Back to cited text no. 103
    
104.
Parati G, Agostoni P, Basnyat B, Bilo G, Brugger H, Coca A, et al. Clinical recommendations for high altitude exposure of individuals with pre-existing cardiovascular conditions: A joint statement by the European Society of Cardiology, the Council on Hypertension of the European Society of Cardiology, the European Society of Hypertension, the International Society of Mountain Medicine, the Italian Society of Hypertension and the Italian Society of Mountain Medicine. Eur Heart J 2018;39:1546-54.  Back to cited text no. 104
    
105.
Franklin BA. Preventing exercise-related cardiovascular events: Is a medical examination more urgent for physical activity or inactivity? Circulation 2014;129:1081-4.  Back to cited text no. 105
    
106.
Auger N, Potter BJ, Smargiassi A, Bilodeau-Bertrand M, Paris C, Kosatsky T. Association between quantity and duration of snowfall and risk of myocardial infarction. CMAJ 2017;189:E235-42.  Back to cited text no. 106
    
107.
Northcote RJ, Flannigan C, Ballantyne D. Sudden death and vigorous exercise – A study of 60 deaths associated with squash. Br Heart J 1986;55:198-203.  Back to cited text no. 107
    
108.
Giannuzzi P, Temporelli PL, Marchioli R, Maggioni AP, Balestroni G, Ceci V, et al. Global secondary prevention strategies to limit event recurrence after myocardial infarction: Results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network. Arch Intern Med 2008;168:2194-204.  Back to cited text no. 108
    
109.
Chow CK, Jolly S, Rao-Melacini P, Fox KA, Anand SS, Yusuf S. Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation 2010;121:750-8.  Back to cited text no. 109
    
110.
Kotseva K, De Backer G, De Bacquer D, Rydén L, Hoes A, Grobbee D, et al. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. Eur J Prev Cardiol 2019;26:824-35.  Back to cited text no. 110
    
111.
Hamer M, O'Donovan G, Murphy M. Physical inactivity and the economic and health burdens due to cardiovascular disease: Exercise as medicine. Adv Exp Med Biol 2017;999:3-18.  Back to cited text no. 111
    
112.
O'Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 2009;301:1439-50.  Back to cited text no. 112
    
113.
Greco A, Brugnera A, Adorni R, D'Addario M, Fattirolli F, Franzelli C, et al. Protein intake and physical activity in newly diagnosed patients with acute coronary syndrome: A 5-year longitudinal study. Nutrients 2021;13:634.  Back to cited text no. 113
    
114.
Conraads VM, Deaton C, Piotrowicz E, Santaularia N, Tierney S, Piepoli MF, et al. Adherence of heart failure patients to exercise: Barriers and possible solutions: A position statement of the Study Group on Exercise Training in Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2012;14:451-8.  Back to cited text no. 114
    
115.
Rosenfeld CS. Sex-dependent differences in voluntary physical activity. J Neurosci Res 2017;95:279-90.  Back to cited text no. 115
    
116.
Adorni R, Greco A, D'Addario M, Zanatta F, Fattirolli F, Franzelli C, et al. Sense of coherence predicts physical activity maintenance and health-related quality of life: A 3-year longitudinal study on cardiovascular patients. Int J Environ Res Public Health 2022;19:4700.  Back to cited text no. 116
    
117.
Tofler GH, Muller JE, Stone PH, Forman S, Solomon RE, Knatterud GL, et al. Modifiers of timing and possible triggers of acute myocardial infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study Group. J Am Coll Cardiol 1992;20:1049-55.  Back to cited text no. 117
    
118.
Siegel AJ, Noakes TD. Can pre-race aspirin prevent sudden cardiac death during marathons? Br J Sports Med 2017;51:1579-81.  Back to cited text no. 118
    
119.
Bassler TJ. Marathon running and immunity to heart disease. Phys Sportsmed 1975;3:77-80.  Back to cited text no. 119
    
120.
Trivax JE, Franklin BA, Goldstein JA, Chinnaiyan KM, Gallagher MJ, deJong AT, et al. Acute cardiac effects of marathon running. J Appl Physiol (1985) 2010;108:1148-53.  Back to cited text no. 120
    
121.
Aengevaeren VL, Mosterd A, Braber TL, Prakken NH, Doevendans PA, Grobbee DE, et al. Relationship between lifelong exercise volume and coronary atherosclerosis in athletes. Circulation 2017;136:138-48.  Back to cited text no. 121
    
122.
Hansen D, Dendale P, Coninx K, Vanhees L, Piepoli MF, Niebauer J, et al. The European Association of Preventive Cardiology Exercise Prescription in Everyday Practice and Rehabilitative Training (EXPERT) tool: A digital training and decision support system for optimized exercise prescription in cardiovascular disease. Concept, definitions and construction methodology. Eur J Prev Cardiol 2017;24:1017-31.  Back to cited text no. 122
    
123.
Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019;140:e596-646.  Back to cited text no. 123
    
124.
Riebe D, Franklin BA, Thompson PD, Garber CE, Whitfield GP, Magal M, et al. Updating ACSM's recommendations for exercise preparticipation health screening. Med Sci Sports Exerc 2015;47:2473-9.  Back to cited text no. 124
    


    Figures

  [Figure 1]



 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
Abstract
Introduction
Main Causes of E...
Screening for Pa...
Cardiac Screenin...
Cardiac Screenin...
Education of Fit...
Prudence of Exercise
Adherence to Exe...
Novel Prevention...
How Can the Guid...
Conclusions
References
Article Figures

 Article Access Statistics
    Viewed999    
    Printed28    
    Emailed0    
    PDF Downloaded105    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]